MODKIFY Trademark

Trademark Overview


On Friday, July 24, 2020, a trademark application was filed for MODKIFY with the United States Patent and Trademark Office. The USPTO has given the MODKIFY trademark a serial number of 79294183. The federal status of this trademark filing is REGISTERED as of Tuesday, August 31, 2021. This trademark is owned by CSL Behring GmbH. The MODKIFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits co...
modkify

General Information


Serial Number79294183
Word MarkMODKIFY
Filing DateFriday, July 24, 2020
Status700 - REGISTERED
Status DateTuesday, August 31, 2021
Registration Number6465740
Registration DateTuesday, August 31, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza
Pseudo MarkMODIFY

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Behring GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
Address35041 Marburg
DE

Party NameCSL Behring GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
Address35041 Marburg
DE

Party NameCSL Behring GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
Address35041 Marburg
DE

Trademark Events


Event DateEvent Description
Friday, November 4, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 7, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 10, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 10, 2022FINAL DISPOSITION PROCESSED
Tuesday, November 30, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 31, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 20, 2020REFUSAL PROCESSED BY IB
Thursday, December 3, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 3, 2020REFUSAL PROCESSED BY MPU
Tuesday, November 17, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 16, 2020NON-FINAL ACTION WRITTEN
Wednesday, November 11, 2020ASSIGNED TO EXAMINER
Friday, October 2, 2020APPLICATION FILING RECEIPT MAILED
Monday, September 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB